IPO SnapShot

METROPOLIS HEALTHCARE LTD.

IPODATE
Apr 03, 2019 TO Apr 05, 2019
LISTINGDATE
4/15/2019 12:00:00 AM
APPLY NOW
FACEVALUE
₹ 2

per share

ISSUESIZE
₹ 1204.29 Cr
PRICEBAND
₹ 877 - ₹ 880

per share

MARKETLOT
17

shares

OBJECTIVE

The objects of the Offer are to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the Offer for Sale. Further, our Company expects that listing of the Equity Shares will enhance our visibility and brand image and provide liquidity to our Shareholders.

DON'T HAVE A DEMAT ACCOUNT

OPENDEMAT ACCOUNTAND START YOURINVESTMENTJOURNEY WITH US

OPEN AN ACCOUNT (You will receive a call & SMS from our end)
BUSINESS DESCRIPTION

No Description found

ADDRESS

Address: 4th Floor
East Wing
Plot-254 B
Nirlon House
Dr. Annie Besant Road
Worli
City: Mumbai,
State: Maharashtra
Pincode: 400030
Phone: 022 6258 2810 / 8422 801 801
Email: support@metropolisindia.com / secretarial@metropolisindia.com
Website: www.metropolisindia.com

LISTED AT

BSE, NSE

LEAD MANAGER

Credit Suisse Securities (India) Pvt Ltd.
Goldman Sachs (India) Securities Pvt Ltd
HDFC Bank Ltd.
JM Financial Ltd.
Kotak Mahindra Capital Co Ltd

PROMOTERS

Ameera Sushil Shah
Metz Advisory LLP
Sushil Kanubhai Shah

PROMOTER'S HOLDING

Total Share Capital

34018785

Offered to Public

13685095

Promoter's Holding (Pre-Issue)

67.8

Promoter's Holding (Post-Issue)

57.41
REGISTRAR

Link Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.